Related Experiment Video

Updated: Aug 22, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Modulation of Janus kinase 2 by p53 in ovarian cancer cells

Thomas Reid1, Xiaohong Jin, Hui Song

  • 1Cellular and Molecular Biology Graduate Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109-0936, USA.

Biochemical and Biophysical Research Communications
|September 11, 2004
PubMed

Insights

Wild-type p53 suppresses Janus kinase 2 (JAK2) phosphorylation in ovarian cancer cells. This suggests a p53-dependent mechanism for regulating JAK2 activity in cancer, potentially involving Protein tyrosine phosphatase 1-B.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Constitutive activation of Janus kinase 2 (JAK2) and p53 tumor suppressor mutations are common in human cancers.
  • Ovarian cancer cell lines (Caov-3, MDAH2774) exhibit high levels of phosphorylated JAK2 and harbor mutant p53.
  • Understanding the interplay between p53 and JAK2 is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the regulatory role of wild-type p53 on JAK2 phosphorylation in human ovarian cancer cell lines.
  • To determine if p53-mediated regulation of JAK2 phosphorylation is specific or affects other kinases.
  • To explore the potential involvement of phosphatases in the p53-dependent dephosphorylation of JAK2.

Main Methods:

  • Re-introduction of wild-type p53 and mutant p53 variants into ovarian cancer cells using adenovirus vectors.
  • Assessment of JAK2 tyrosine phosphorylation levels via Western blotting or similar techniques.
  • Evaluation of the effect of p53 on the phosphorylation of unrelated kinases (ERK1/2) and the impact of tyrosine phosphatase inhibitors.

Main Results:

  • Wild-type p53 expression significantly diminished JAK2 tyrosine phosphorylation in MDAH2774 and Caov-3 cells.
  • Mutant p53 (p53-175) did not reduce JAK2 phosphorylation, while p53 22/23 showed no effect.
  • JAK2 dephosphorylation was reversed by sodium orthovanadate, and Protein tyrosine phosphatase 1-B levels increased with wild-type p53 expression.
  • Phosphorylation of ERK1/2 remained unaffected, indicating specificity of p53's action on JAK2.

Conclusions:

  • Wild-type p53 can directly inhibit JAK2 tyrosine phosphorylation in ovarian cancer cells.
  • This regulation appears to be mediated, at least in part, by Protein tyrosine phosphatase 1-B.
  • These findings reveal a novel p53-dependent pathway for modulating JAK2 activity in ovarian cancer.

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.